FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

André Delacourte

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Phenomena

Physiology

Brain Chemistry

Co-author Network

Publications

TOP 3
André Delacourte; Jean-François Dartigues; François Sztark
[Alzheimer's disease and anaesthesia: potential relationships and clinical implications].
Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T DeKosky; Pascale Barberger-Gateau; André Delacourte; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; S Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin N Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip scheltens
Revising the definition of Alzheimer's disease: a new lexicon.
Eloise Hudry; Debby Van Dam; Wim Kulik; Peter P De Deyn; Femke S Stet; Ornella Ahouansou; Abdellatif Benraiss; André Delacourte; Pierre Bougnères; Patrick Aubourg; Nathalie Cartier
Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of André Delacourte (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: André Delacourte; Jean-François Dartigues; François Sztark
[Alzheimer's disease and anaesthesia: potential relationships and clinical implications].
Annales françaises d'anesthèsie et de rèanimation 2011;30(1):37-46.
2010: Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T DeKosky; Pascale Barberger-Gateau; André Delacourte; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; S Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin N Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip scheltens
Revising the definition of Alzheimer's disease: a new lexicon.
Lancet neurology 2010;9(11):1118-27.
2010: Eloise Hudry; Debby Van Dam; Wim Kulik; Peter P De Deyn; Femke S Stet; Ornella Ahouansou; Abdellatif Benraiss; André Delacourte; Pierre Bougnères; Patrick Aubourg; Nathalie Cartier
Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(1):44-53.
2009: Dominique Caparros-Lefebvre; Olivier Kerdraon; David Devos; C M Dhaenens; David Blum; Claude-Alain Maurage; André Delacourte; Bernard Sablonnière
Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):1089-90.
2009: Nikita Rudinskiy; Yulia Grishchuk; Anne Vaslin; Julien Puyal; André Delacourte; Harald Hirling; Peter G H Clarke; Ruth Luthi-Carter
Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.
The Journal of biological chemistry 2009;284(18):12447-58.
2009: Giovanni B Frisoni; André Delacourte
Neuroimaging outcomes in clinical trials in Alzheimer's disease.
The journal of nutrition, health & aging 2009;13(3):209-12.
2009: Sébastien S Hébert; Katrien Horré; Laura Nicolaï; Bruno Bergmans; Aikaterini S Papadopoulou; André Delacourte; Bart De Strooper
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.
Neurobiology of disease 2009;33(3):422-8.
2009: Amantha Thathiah; Kurt Spittaels; Marcel Hoffmann; Mik Staes; Adrian Cohen; Katrién Horré; Mieke Vanbrabant; Frea Coun; Veerle Baekelandt; André Delacourte; David F Fischer; Dirk Pollet; Bart De Strooper; Pascal Merchiers
The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons.
Science (New York, N.Y.) 2009;323(5916):946-51.
2008: Alireza Kashani; Eve Lepicard; Odile Poirel; Catherine Videau; Jean Philippe David; Catherine Fallet-Bianco; Axelle Simon; André Delacourte; Bruno GIROS; Jacques Epelbaum; Catalina Betancur; Salah El Mestikawy
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
Neurobiology of aging 2008;29(11):1619-30.
2008: André Delacourte
Tau pathology and neurodegeneration: an obvious but misunderstood link.
Journal of Alzheimer's disease : JAD 2008;14(4):437-40.
2008: Sébastien S Hébert; Katrien Horré; Laura Nicolaï; Aikaterini S Papadopoulou; Wim Mandemakers; Asli N Silahtaroglu; Sakari Kauppinen; André Delacourte; Bart De Strooper
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(17):6415-20.
2008: Nicolas Sergeant; Alexis Bretteville; Malika Hamdane; Marie-Laure Caillet-Boudin; Pierre Grognet; Stephanie Bombois; David Blum; André Delacourte; Florence Pasquier; Eugeen Vanmechelen; Susanna Schraen-Maschke; Luc BUEE
Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
Expert review of proteomics 2008;5(2):207-24.
2008: C M Dhaenens; Susanna Schraen-Maschke; H Tran; V Vingtdeux; D Ghanem; O Leroy; J Delplanque; E Vanbrussel; André Delacourte; Patrick Vermersch; Claude-Alain Maurage; Gruffat Henri; A Sergeant; M S Mahadevan; S Ishiura; Luc BUEE; T A Cooper; Marie-Laure Caillet-Boudin; N Charlet-Berguerand; B Sablonnière; N Sergeant
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Experimental neurology 2008;210(2):467-78.
2008: André Delacourte
Tau, a biological marker of neurodegenerative diseases.
Handbook of clinical neurology 2008;89():161-72.
2007: Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T DeKosky; Pascale Barberger-Gateau; Jeffrey L Cummings; André Delacourte; Douglas Galasko; S Gauthier; Gregory A Jicha; Kenichi Meguro; John T O'Brien; Florence Pasquier; Philippe Robert; Martin N Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip scheltens
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Lancet neurology 2007;6(8):734-46.
2007: Mathias Cacquevel; Séverine Launay; Hervé Castel; Karim Benchenane; Simon Chéenne; Luc BUEE; Lieve Moons; André Delacourte; Peter Carmeliet; Denis Vivien
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
Neurobiology of disease 2007;27(2):164-73.
2007: Valérie Vingtdeux; Malika Hamdane; Anne Loyens; Patrick Gelé; Hervé Drobeck; Séverine Bégard; Marie-Christine Galas; André Delacourte; Jean-Claude Beauvillain; Luc BUEE; Nicolas Sergeant
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies.
The Journal of biological chemistry 2007;282(25):18197-205.
2007: Huifang Ma; Sylvain Lesné; Linda Kotilinek; Jill V Steidl-Nichols; Mathew Sherman; Linda Younkin; Steven G Younkin; Colleen Forster; Nicolas Sergeant; André Delacourte; Robert Vassar; Martin Citron; Paulo Kofuji; Linda M Boland; Karen K. Hsiao Ashe
Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(19):8167-72.
2007: Stéphanie Bombois; Claude-Alain Maurage; Marie Gompel; Vincent Deramecourt; Marie-Anne Mackowiak-Cordoliani; Ronald S Black; Rodolphe Lavielle; André Delacourte; Florence Pasquier
Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
Archives of neurology 2007;64(4):583-7.
2007: Valérie Vingtdeux; Malika Hamdane; Séverine Bégard; Anne Loyens; André Delacourte; Jean-Claude Beauvillain; Luc BUEE; Philippe Marambaud; Nicolas Sergeant
Intracellular pH regulates amyloid precursor protein intracellular domain accumulation.
Neurobiology of disease 2007;25(3):686-96.
2007: Stéphanie Boutillier; Béatrice Lannes; Luc BUEE; André Delacourte; Caroline Rouaux; Michel Mohr; Jean-Pierre Bellocq; François Sellal; Yves Larmet; Anne-Laurence Boutillier; Jean-Philippe Loeffler
Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
Neuro-degenerative diseases 2007;4(6):413-23.
2007: Teresa A Evans; Arun K Raina; André Delacourte; Olga Aprelikova; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A. Smith
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
International journal of medical sciences 2007;4(3):140-5.
2006: Luc BUEE; André Delacourte
[Tauopathy and Alzheimer disease: a full degenerating process].
Psychologie & neuropsychiatrie du vieillissement 2006;4(4):261-73.
2006: André Delacourte
[From physiopathology to treatment of Alzheimer's disease].
Revue neurologique 2006;162(10):909-12.
2006: Olivier Leroy; Claire-Marie Dhaenens; Susanna Schraen-Maschke; Karim Belarbi; André Delacourte; Athena Andreadis; Bernard Sablonnière; Luc BUEE; Nicolas Sergeant; Marie-Laure Caillet-Boudin
ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
Journal of neuroscience research 2006;84(4):852-9.
2006: Marianne Husson; Valérie Enderlin; André Delacourte; Nadirah Ghenimi; Serge Alfos; Véronique Pallet; Paul Higueret
Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats.
Neurobiology of disease 2006;23(1):1-10.
2006: Malika Hamdane; Pierre Dourlen; Alexis Bretteville; Anne-Véronique Sambo; Stéphanie Ferreira; Kunie Ando; Olivier Kerdraon; Séverine Bégard; Linda Geay; Guy Lippens; Nicolas Sergeant; André Delacourte; Claude-Alain Maurage; Marie-Christine Galas; Luc BUEE
Pin1 allows for differential Tau dephosphorylation in neuronal cells.
Molecular and cellular neurosciences 2006;32(1-2):155-60.
2006: Vincent Deramecourt; Stéphanie Bombois; Claude-Alain Maurage; Antoine Ghestem; Hervé Drobecq; Eugeen Vanmechelen; Florence Lebert; Florence Pasquier; André Delacourte
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Journal of neuropathology and experimental neurology 2006;65(3):278-88.
2006: André Delacourte
The natural and molecular history of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):187-94.
2005: André Delacourte; Luc BUEE
[Animal models of Alzheimer's disease: a road full of pitfalls].
Psychologie & neuropsychiatrie du vieillissement 2005;3(4):261-70.
2005: C A Maurage; Bjarne Udd; Marie-Magdeleine Ruchoux; P Vermersch; Hannu Kalimo; Ralf Krahe; André Delacourte; Nicolas Sergeant
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease.
Neurology 2005;65(10):1636-8.
2005: Valérie Vingtdeux; Malika Hamdane; Marie Gompel; Séverine Bégard; Hervé Drobecq; Antoine Ghestem; Marie-Eve Grosjean; Vesna Kostanjevecki; Pierre Grognet; Eugeen Vanmechelen; Luc BUEE; André Delacourte; Nicolas Sergeant
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Neurobiology of disease 2005;20(2):625-37.
2005: Dominique Santiard-Baron; Dominique Langui; Maryse DELEHEDDE; Benoît Delatour; Brigitte Schombert; Nathalie Touchet; Günter Tremp; Marie-Françoise Paul; Véronique Blanchard; Nicolas Sergeant; André Delacourte; Charles Duyckaerts; Laurent Pradier; Luc Mercken
Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.
Journal of neurochemistry 2005;93(2):330-8.
2005: Malika Hamdane; Alexis Bretteville; Anne-Véronique Sambo; Katharina Schindowski; Séverine Bégard; André Delacourte; Philippe Bertrand; Luc BUEE
p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
Journal of cell science 2005;118(Pt 6):1291-8.
2005: Enzo Lain; Botond Penke; André Delacourte; Daniela Gündisch; Hannsjörg Schröder; Brigitte Witter
Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro.
The European journal of neuroscience 2005;21(4):879-88.
2005: Patrice Delobel; O Leroy; Malika Hamdane; Anne-Véronique Sambo; André Delacourte; Luc BUEE
Proteasome inhibition and Tau proteolysis: an unexpected regulation.
FEBS letters 2005;579(1):1-5.
2005: Nicolas Sergeant; André Delacourte; Luc BUEE
Tau protein as a differential biomarker of tauopathies.
Biochimica et biophysica acta 2005;1739(2-3):179-97.
2005: André Delacourte
Tauopathies: recent insights into old diseases.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2005;43(4):244-57.
2004: José Abad-Rodríguez; Maria Dolores Ledesma; Katleen Craessaerts; Simona Perga; Miguel Medina; André Delacourte; Colin Dingwall; Bart De Strooper; Carlos G Dotti
Neuronal membrane cholesterol loss enhances amyloid peptide generation.
The Journal of cell biology 2004;167(5):953-60.
2004: C-A Maurage; Thierry Bussière; Nicolas Sergeant; A Ghesteem; D Figarella-Branger; Marie-Magdeleine Ruchoux; J-F Pellissier; André Delacourte
Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Neuropathology and applied neurobiology 2004;30(6):624-34.
2004: Benoît Funalot; Tanja Ouimet; A Claperon; C Fallet; André Delacourte; Jacques Epelbaum; T Subkowski; N Léonard; Valérie Codron; J-P David; Philippe Amouyel; J-C Schwartz; Nicole Helbecque
Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
Molecular psychiatry 2004;9(12):1122-8, 1059.
2004: caty casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesus Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
The American journal of pathology 2004;165(4):1289-300.
2004: Igor Sibon; Frédéric Macia; Anne Vital; André Delacourte; François Tison
Hypertension and progressive supranuclear palsy: is everything so clear?
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1259-61.
2004: Jorge Guevara; H Dilhuydy; Blanca Espinosa; André Delacourte; R Quirion; Raúl Mena; Yves Joanette; Edgar Zenteno; Yvonne Robitaille
Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains.
Histology and histopathology 2004;19(4):1075-84.
2004: Claire-Marie Dhaenens; Edwige Van Brussel; Susanna Schraen-Maschke; Florence Pasquier; André Delacourte; Bernard Sablonnière
Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease.
Neuroscience letters 2004;368(3):290-2.
2004: Isabelle Le Ber; Maria Martinez; Dominique Campion; Annie Laquerrière; Christine Bétard; guillaume bassez; Carol Girard; Pascale Saugier-Veber; Gregory RAUX; Nicolas Sergeant; Patrick Magnier; Thierry Maisonobe; Bruno Eymard; Charles Duyckaerts; André Delacourte; Thierry Frebourg; Didier Hannequin
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Brain : a journal of neurology 2004;127(Pt 9):1979-92.
2004: Roberta Borghi; Alessandra Piccini; André Delacourte; Paola Strocchi; Damiano Zaccheo; Massimo Tabaton
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy.
Neuroscience letters 2004;366(1):67-70.
2004: Cathia Soulié; Annie Nicole; André Delacourte; Irène Ceballos-Picot
Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process.
Neuroscience letters 2004;365(1):1-5.
2004: Susanna Schraen-Maschke; Claire-Marie Dhaenens; André Delacourte; Bernard Sablonnière
Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
Neurobiology of disease 2004;15(3):449-60.
2003: Patrice Delobel; Christel Mailliot; Malika Hamdane; Anne-Véronique Sambo; Séverine Bégard; Anne Violleau; André Delacourte; Luc BUEE
Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.
Annals of the New York Academy of Sciences 2003;1010():623-34.
2003: Maria Dolores Ledesma; José Abad-Rodríguez; Cristian Galvan; Elisa Biondi; Pilar Navarro; André Delacourte; Colin Dingwall; Carlos G Dotti
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains.
EMBO reports 2003;4(12):1190-6.
2003: Claude-Alain Maurage; Nicolas Sergeant; Susanna Schraen-Maschke; Florence Lebert; Marie-Magdeleine Ruchoux; Bernard Sablonnière; Florence Pasquier; André Delacourte
Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease.
Acta neuropathologica 2003;106(6):575-83.
2003: André Delacourte; Nicolas Sergeant; Luc BUEE
In vitro models of age-related neurodegenerative disorders.
Experimental gerontology 2003;38(11-12):1309-17.
2003: Malika Hamdane; Patrice Delobel; Anne-Véronique Sambo; Caroline Smet; Séverine Bégard; Anne Violleau; Isabelle Landrieu; André Delacourte; Guy Lippens; Stéphane Flament; Luc BUEE
Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis?
Biochemical pharmacology 2003;66(8):1619-25.
2003: Malika Hamdane; Anne-Véronique Sambo; Patrice Delobel; Séverine Bégard; Anne Violleau; André Delacourte; Philippe Bertrand; Jesus Benavides; Luc BUEE
Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex.
The Journal of biological chemistry 2003;278(36):34026-34.
2003: Nicolas Sergeant; Stéphanie Bombois; Antoine Ghestem; Hervé Drobecq; Vesna Kostanjevecki; Carla Missiaen; Annick Wattez; Jean-Philippe David; Eugeen Vanmechelen; Christian Sergheraert; André Delacourte
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach.
Journal of neurochemistry 2003;85(6):1581-91.
2003: Sylvain Lesné; Fabian Docagne; Cecilia Gabriel; Géraldine Liot; Debomoy K Lahiri; Luc BUEE; Laurent Plawinski; André Delacourte; Eric T MacKenzie; Alain Buisson; Denis Vivien
Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice.
The Journal of biological chemistry 2003;278(20):18408-18.
2003: Sébastien Weill-Engerer; Jean Philippe David; Véronique Sazdovitch; Philippe Liere; Michael Schumacher; André Delacourte; Etienne Baulieu; Yvette Akwa
In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients.
Brain research 2003;969(1-2):117-25.
2003: Claude-Alain Maurage; Nicolas Sergeant; Marie-Magdeleine Ruchoux; JEAN-JACQUES HAUW; André Delacourte
Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Acta neuropathologica 2003;105(2):89-97.
2003: Tony Lefebvre; Stéphanie Ferreira; Laetitia Dupont-Wallois; Thierry Bussière; Marie-Joëlle Dupire; André Delacourte; Jean-Claude Michalski; Marie-Laure Caillet-Boudin
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Biochimica et biophysica acta 2003;1619(2):167-76.
2003: Tony Lefebvre; Marie-Laure Caillet-Boudin; Luc BUEE; André Delacourte; Jean-Claude Michalski
O-GlcNAc glycosylation and neurological disorders.
Advances in experimental medicine and biology 2003;535():189-202.
2003: R Winsky-Sommerer; Dominique Grouselle; Catherine Rougeot; V Laurent; J-P David; André Delacourte; Pascal Dournaud; N G Seidah; Iris Lindberg; S Trottier; Jacques Epelbaum
The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease.
Neuroscience 2003;122(2):437-47.
2003: David G Munoz; dennis dickson; Catherine Bergeron; Ian R A Mackenzie; André Delacourte; Victoria Zhukareva
The neuropathology and biochemistry of frontotemporal dementia.
Annals of neurology 2003;54 Suppl 5():S24-8.
2003: Donald Royall; Gustavo C Román; André Delacourte
Pathological determinants of dementia in Alzheimer's disease (AD).
Experimental aging research 2003;29(1):107-10.
2003: Nicolas Sergeant; Annick Wattez; M Galván-valencia; Antoine Ghestem; Jean-Philippe David; J Lemoine; P-E Sautiére; J Dachary; J-P Mazat; Jean-Claude Michalski; J Velours; R Mena-López; André Delacourte
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease.
Neuroscience 2003;117(2):293-303.
2002: Malika Hamdane; Caroline Smet; Anne-Véronique Sambo; Arnaud Leroy; Jean-Michel Wieruszeski; Patrice Delobel; Claude-Alain Maurage; Antoine Ghestem; René Wintjens; Séverine Bégard; Nicolas Sergeant; André Delacourte; Dragos Horvath; Isabelle Landrieu; Guy Lippens; Luc BUEE
Pin1: a therapeutic target in Alzheimer neurodegeneration.
Journal of molecular neuroscience : MN 2002;19(3):275-87.
2002: Sébastien Weill-Engerer; Jean-Philippe David; Véronique Sazdovitch; Philippe Liere; Bernard Eychenne; Antoine Pianos; Michael Schumacher; André Delacourte; Etienne Baulieu; Yvette Akwa
Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.
The Journal of clinical endocrinology and metabolism 2002;87(11):5138-43.
2002: André Delacourte; Nicolas Sergeant; Annick Wattez; Claude-Alain Maurage; Florence Lebert; Florence Pasquier; Jean-Philippe David
Tau aggregation in the hippocampal formation: an ageing or a pathological process?
Experimental gerontology 2002;37(10-11):1291-6.
2002: Patrice Delobel; Stéphane Flament; Malika Hamdane; Christel Mailliot; Anne-Véronique Sambo; Séverine Bégard; Nicolas Sergeant; André Delacourte; Jean-Pierre Vilain; Luc BUEE
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis.
Journal of neurochemistry 2002;83(2):412-20.
2002: Markus Tolnay; Nicolas Sergeant; Antoine Ghestem; Sonia Chalbot; Rob A I de Vos; Ernst N H Jansen Steur; Alphonse Probst; André Delacourte
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Acta neuropathologica 2002;104(4):425-34.
2002: André Delacourte; Nicolas Sergeant; D Champain; Annick Wattez; Claude-Alain Maurage; Florence Lebert; Florence Pasquier; Jean-Philippe David
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.
Neurology 2002;59(3):398-407.
2002: Nicolas Sergeant; Jean-Philippe David; Danie Champain; Antoine Ghestem; Annick Wattez; André Delacourte
Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.
Journal of neurochemistry 2002;81(4):663-72.
2002: Patrice Delobel; Stéphane Flament; Malika Hamdane; André Delacourte; Jean-Pierre Vilain; Luc BUEE
Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.
FEBS letters 2002;516(1-3):151-5.
2002: Donald Royall; Raymond Palmer; Amy R Mulroy; Marsha Polk; Gustavo C Román; Jean-Phillippe David; André Delacourte
Pathological determinants of the transition to clinical dementia in Alzheimer's disease.
Experimental aging research 2002;28(2):143-62.
2002: Dominique Caparros-Lefebvre; Nicolas Sergeant; Andrew J Lees; Agnès Camuzat; Susan E Daniel; Annie Lannuzel; Alexis Brice; Eduardo Tolosa; André Delacourte; Charles Duyckaerts
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Brain : a journal of neurology 2002;125(Pt 4):801-11.
2002: Patrice Delobel; Stéphane Flament; Malika Hamdane; Ross Jakes; Arlette Rousseau; André Delacourte; Jean-Pierre Vilain; Michel Goedert; Luc BUEE
Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation.
The Journal of biological chemistry 2002;277(11):9199-205.
2002: Roberta Borghi; Luca Giliberto; Andrea Assini; André Delacourte; George Perry; Mark A. Smith; Paola Strocchi; Damiano Zaccheo; Massimo Tabaton
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
Neurology 2002;58(4):589-92.
2002: Luc BUEE; Malika Hamdane; Patrice Delobel; Anne-Véronique Sambo; Séverine Bégard; Antoine Ghestem; Nicolas Sergeant; André Delacourte
[Tau story: from frontotemporal dementia to other tauopathies].
Journal de la Société de biologie 2002;196(1):103-8.
2002: Nöelle Bons; Sylvain Lehmann; Noriyuki Nishida; Nadine Mestre-Frances; Dominique Dormont; Patrick Belli; André Delacourte; Jacques Grassi; Paul Brown
BSE infection of the small short-lived primate Microcebus murinus.
Comptes rendus biologies 2002;325(1):67-74.
2001: Hervé SEZNEC; Onnik Agbulut; Nicolas Sergeant; Cédric Savouret; Antoine Ghestem; Nacira Tabti; Jean-Claude Willer; L Ourth; C Duros; Edith Brisson; C Fouquet; Gillian Butler-Browne; André Delacourte; Claudine Junien; Geneviève Gourdon
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Human molecular genetics 2001;10(23):2717-26.
2001: C A Maurage; Nicolas Sergeant; Marie-Magdeleine Ruchoux; JEAN-JACQUES HAUW; André Delacourte
Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals.
Neuroreport 2001;12(15):3177-81.
2001: Nicolas Sergeant; Bernard Sablonnière; Susanna Schraen-Maschke; Antoine Ghestem; Claude-Alain Maurage; Annick Wattez; Patrick Vermersch; André Delacourte
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.
Human molecular genetics 2001;10(19):2143-55.
2001: B M Riederer; C Mourton-Gilles; P Frey; André Delacourte; A Probst
Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease.
Journal of neurocytology 2001;30(2):145-58.
2001: S Guise; Diane Braguer; Gérard Carles; André Delacourte; Claudette Briand
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
Journal of neuroscience research 2001;63(3):257-67.
2001: André Delacourte
The molecular parameters of tau pathology. Tau as a killer and a witness.
Advances in experimental medicine and biology 2001;487():5-19.
2001: Luc BUEE; André Delacourte; Kirk Wilhelmsen; Bruce L Miller; Daniel Geschwind
Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
Neurobiology of aging 2001;22(1):115-21.
2000: Maria Dolores Ledesma; Jorge Santos da Silva; K Crassaerts; André Delacourte; Bart De Strooper; Carlos G Dotti
Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.
EMBO reports 2000;1(6):530-5.
2000: S Ferreira; Marie-Joëlle Dupire; André Delacourte; J Najib; Marie-Laure Caillet-Boudin
Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons.
Experimental neurology 2000;166(2):415-21.
2000: K Ishizawa; Hanna Ksiezak-Reding; Peter Davies; André Delacourte; P Tiseo; Shu-Hui C. Yen; dennis dickson
A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Acta neuropathologica 2000;100(3):235-44.
2000: André Delacourte; Luc BUEE
Tau pathology: a marker of neurodegenerative disorders.
Current opinion in neurology 2000;13(4):371-6.
2000: Luc BUEE; Thierry Bussière; V Buée-Scherrer; André Delacourte; Patrick R Hof
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
Brain research. Brain research reviews 2000;33(1):95-130.
2000: André Delacourte
[Natural and molecular history of Alzheimer disease].
Annales de biologie clinique 2000;58(3):350-5.
2000: I Litvan; dennis dickson; J A Buttner-Ennever; André Delacourte; Michael Hutton; Bruno Dubois; Lawrence I Golbe; Mark Hallett; Gerard D Schellenberg; D Standaert; David J Brooks; Donald L Price
Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):446-58.
2000: Christel Mailliot; V Podevin-Dimster; Robert E Rosenthal; Nicolas Sergeant; André Delacourte; Gary Fiskum; Luc BUEE
Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(3):543-9.
2000: Christel Mailliot; Thierry Bussière; Malika Hamdane; Nicolas Sergeant; M L Caillet; André Delacourte; Luc BUEE
Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.
Annals of the New York Academy of Sciences 2000;920():107-14.
1999: Luc BUEE; André Delacourte
Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.
Brain pathology (Zurich, Switzerland) 1999;9(4):681-93.
1999: Jordi Pérez-Tur; Luc BUEE; Huw R Morris; S C Waring; Luisa Onstead; Fabienne Wavrant-De Vrièze; Richard Crook; V Buée-Scherrer; Patrick R Hof; Ronald C. Petersen; Patrick L McGeer; André Delacourte; Michael Hutton; Teepu Siddique; J Eric Ahlskog; John Hardy; John C Steele
Neurodegenerative diseases of Guam: analysis of TAU.
Neurology 1999;53(2):411-3.
1999: Naoyuki Sato; Osamu Hori; Atsushi Yamaguchi; jean-charles lambert; M C Chartier-Harlin; P A Robinson; André Delacourte; Ann Marie Schmidt; T Furuyama; Kazunori Imaizumi; Masaya Tohyama; T Takagi
A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue.
Journal of neurochemistry 1999;72(6):2498-505.
1999: Cathia Soulié; V Mitchell; Laetitia Dupont-Wallois; M C Chartier-Harlin; Jean-Claude Beauvillain; André Delacourte; Marie-Laure Caillet-Boudin
Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE.
Neuroscience letters 1999;265(2):147-50.
1999: André Delacourte; Jean-Philippe David; Nicolas Sergeant; Luc BUEE; Annick Wattez; Patrick Vermersch; F Ghozali; C Fallet-Bianco; Florence Pasquier; Florence Lebert; H Petit; C Di Menza
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Neurology 1999;52(6):1158-65.
1999: Thierry Bussière; Patrick R Hof; Christel Mailliot; C D Brown; Marie-Laure Caillet-Boudin; Daniel P Perl; Luc BUEE; André Delacourte
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
Acta neuropathologica 1999;97(3):221-30.
1999: Nicolas Sergeant; Annick Wattez; André Delacourte
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
Journal of neurochemistry 1999;72(3):1243-9.
1999: S Brique; Alain Destée; jean-charles lambert; Vincent Mouroux; André Delacourte; Philippe Amouyel; Marie-Christine Chartier-Harlin
A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form.
Neuroreport 1999;10(3):487-91.
1999: André Delacourte
Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
Dementia and geriatric cognitive disorders 1999;10 Suppl 1():75-9.
1998: Dominique Grouselle; R Winsky-Sommerer; J P David; André Delacourte; Pascal Dournaud; Jacques Epelbaum
Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
Neuroscience letters 1998;255(1):21-4.
1998: Christel Mailliot; Thierry Bussière; Marie-Laure Caillet-Boudin; André Delacourte; Luc BUEE
Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation.
Neuroscience letters 1998;255(1):13-6.
1998: Florence Pasquier; André Delacourte
Non-Alzheimer degenerative dementias.
Current opinion in neurology 1998;11(5):417-27.
1998: jean-charles lambert; C Berr; Florence Pasquier; André Delacourte; Bernard Frigard; Dominique Cottel; Jordi Pérez-Tur; Vincent Mouroux; M Mohr; D Cécyre; Douglas Galasko; Corinne Lendon; J Poirier; John Hardy; D M A Mann; Philippe Amouyel; Marie-Christine Chartier-Harlin
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Human molecular genetics 1998;7(9):1511-6.
1998: Christel Mailliot; Nicolas Sergeant; Thierry Bussière; Marie-Laure Caillet-Boudin; André Delacourte; Luc BUEE
Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
FEBS letters 1998;433(3):201-4.
1998: Marie-Laure Caillet-Boudin; Laetitia Dupont-Wallois; Cathia Soulié; André Delacourte
Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells.
Neuroscience letters 1998;250(2):83-6.
1998: P Soyeux; André Delacourte; B Delie; P Lefevre; B Boniface
Influence and optimisation of operating parameters with a new binder in wet granulation. I: use in powder form.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;46(1):95-103.
1998: André Delacourte
[Diagnosis of Alzheimer's disease].
Annales de biologie clinique 1998;56(2):133-42.
1998: André Delacourte; Nicolas Sergeant; Annick Wattez; D Gauvreau; Yvonne Robitaille
Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.
Annals of neurology 1998;43(2):193-204.
1997: jean-charles lambert; Jordi Pérez-Tur; Marie-Joëlle Dupire; Douglas Galasko; D M A Mann; P Amouyel; John Hardy; André Delacourte; Marie-Christine Chartier-Harlin
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.
Human molecular genetics 1997;6(12):2151-4.
1997: Jean-Philippe David; F Ghozali; C Fallet-Bianco; Annick Wattez; S Delaine; B Boniface; C Di Menza; André Delacourte
Glial reaction in the hippocampal formation is highly correlated with aging in human brain.
Neuroscience letters 1997;235(1-2):53-6.
1997: Luc BUEE; Patrick R Hof; André Delacourte
Brain microvascular changes in Alzheimer's disease and other dementias.
Annals of the New York Academy of Sciences 1997;826():7-24.
1997: V Buée-Scherrer; Luc BUEE; B Leveugle; Daniel P Perl; P Vermersch; Patrick R Hof; André Delacourte
Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.
Annals of neurology 1997;42(3):356-9.
1997: Nicolas Sergeant; Jean-Philippe David; Didier Lefranc; Patrick Vermersch; Annick Wattez; André Delacourte
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
FEBS letters 1997;412(3):578-82.
1997: Christine Tranchant; Nicolas Sergeant; Annick Wattez; M Mohr; Jean-Marie Warter; André Delacourte
Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation.
Journal of neurology, neurosurgery, and psychiatry 1997;63(2):240-6.
1997: Nicolas Sergeant; Jean-Philippe David; Michel Goedert; R Jakes; Patrick Vermersch; Luc BUEE; Didier Lefranc; Annick Wattez; André Delacourte
Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.
Journal of neurochemistry 1997;69(2):834-44.
1997: F Wavrant-DeVrièze; Jordi Pérez-Tur; jean-charles lambert; Bernard Frigard; Florence Pasquier; André Delacourte; Philippe Amouyel; John Hardy; Marie-Christine Chartier-Harlin
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.
Neuroscience letters 1997;227(1):68-70.
1997: Laetitia Dupont-Wallois; Cathia Soulié; Nicolas Sergeant; N Wavrant-de Wrieze; M C Chartier-Harlin; André Delacourte; Marie-Laure Caillet-Boudin
ApoE synthesis in human neuroblastoma cells.
Neurobiology of disease 1997;4(5):356-64.
1997: André Delacourte; Luc BUEE
Normal and pathological Tau proteins as factors for microtubule assembly.
International review of cytology 1997;171():167-224.
1996: Marie-Laure Caillet-Boudin; André Delacourte
Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
Neuroreport 1996;8(1):307-10.
1996: jean-charles lambert; Jordi Pérez-Tur; M J Dupire; André Delacourte; Bernard Frigard; Marie-Christine Chartier-Harlin
Analysis of the APOE alleles impact in Down's syndrome.
Neuroscience letters 1996;220(1):57-60.
1996: Patrick Vermersch; Nicolas Sergeant; M M Ruchoux; H Hofmann-Radvanyi; Annick Wattez; H Petit; P Dwailly; André Delacourte
Specific tau variants in the brains of patients with myotonic dystrophy.
Neurology 1996;47(3):711-7.
1996: Didier Lefranc; Patrick Vermersch; J Dallongeville; C Daems-Monpeurt; H Petit; André Delacourte
Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
Neuroscience letters 1996;212(2):91-4.
1996: V Buée-Scherrer; O Condamines; C Mourton-Gilles; R Jakes; Michel Goedert; B Pau; André Delacourte
AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.
Brain research. Molecular brain research 1996;39(1-2):79-88.
1996: Cathia Soulié; J Lépagnol; André Delacourte; Marie-Laure Caillet-Boudin
Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity.
Neuroscience letters 1996;206(2-3):189-92.
1996: André Delacourte; Y Robitaille; Nicolas Sergeant; Luc BUEE; Patrick R Hof; Annick Wattez; A Laroche-Cholette; J Mathieu; P Chagnon; D Gauvreau
Specific pathological Tau protein variants characterize Pick's disease.
Journal of neuropathology and experimental neurology 1996;55(2):159-68.
1996: Philippe Couratier; M Lesort; O Condamines; C Mourton-Gilles; André Delacourte; Jacques Hugon
Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures.
Neuroscience letters 1996;203(3):155-8.
1996: V Buée Scherrer; Patrick R Hof; Luc BUEE; B Leveugle; Patrick Vermersch; Daniel P Perl; C Warren Olanow; André Delacourte
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.
Acta neuropathologica 1996;91(4):351-9.
1996: Luc BUEE; Jordi Pérez-Tur; B Leveugle; V Buée-Scherrer; Elliott J Mufson; A J Loerzel; Marie-Christine Chartier-Harlin; Daniel P Perl; André Delacourte; Patrick R Hof
Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes.
Acta neuropathologica 1996;91(3):247-53.
1995: Jordi Pérez-Tur; Dominique Campion; M Martinez; Alexis Brice; Sandrine Tardieu; Didier Hannequin; Yves Agid; André Delacourte; Françoise Clerget-Darpoux; Marie-Christine Chartier-Harlin
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
American journal of medical genetics 1995;60(6):550-3.
1995: Nicolas Sergeant; Thierry Bussière; Patrick Vermersch; J P Lejeune; André Delacourte
Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins.
Neuroreport 1995;6(16):2217-20.
1995: Patrick Vermersch; Jean-Philippe David; B Frigard; C Fallet-Bianco; Annick Wattez; H Petit; André Delacourte
Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(6):1035-47.
1995: B Permanne; Luc BUEE; Jean-Philippe David; C Fallet-Bianco; C Di Menza; André Delacourte
Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay.
Brain research 1995;685(1-2):154-62.
1995: Luc BUEE; B Permanne; Jordi Pérez-Tur; Marie-Christine Chartier-Harlin; André Delacourte
Alzheimer's disease: A beta or ApoE amyloidosis?
Lancet 1995;346(8966):59.
1995: Nöelle Bons; V Jallageas; S Silhol; N Mestre-Frances; A Petter; André Delacourte
Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(7):741-7.
1995: O Condamines; V Buée-Scherrer; L Boissier; A Wattez; André Delacourte; Bernard Pau; C Mourton-Gilles
New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins.
Neuroscience letters 1995;192(2):81-4.
1995: V Buée-Scherrer; Luc BUEE; Patrick R Hof; B Leveugle; C Gilles; A J Loerzel; Daniel P Perl; André Delacourte
Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
The American journal of pathology 1995;146(4):924-32.
1995: P Vermersch; R Bordet; F Ledoze; M M Ruchoux; F Chapon; Pierre Thomas; Alain Destée; B Lechevallier; André Delacourte
[Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(4):439-45.
1995: Laetitia Dupont-Wallois; P E Sautière; C Cocquerelle; B Bailleul; André Delacourte; Marie-Laure Caillet-Boudin
Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid.
FEBS letters 1995;357(2):197-201.
1995: S Reig; V Buée-Scherrer; C Mourton-Gilles; A Defossez; André Delacourte; Jean-Claude Beauvillain; M Mazzuca
Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies.
Acta neuropathologica 1995;90(5):441-7.
1995: André Delacourte; P E Sautière; A Wattez; C Mourton-Gilles; A Petter; Nöelle Bons
Biochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(1):85-9.
1995: Nöelle Bons; V Jallageas; S Silhol; N Mestre-Frances; A Petter; André Delacourte
Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(1):77-83.
1994: Panteleimon Giannakopoulos; Patrick R Hof; A S Giannakopoulos; V Buée-Scherrer; M Surini; André Delacourte; Constantin Bouras
Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital.
Dementia (Basel, Switzerland) 1994;5(6):348-56.
1994: James C Vickers; Beat M Riederer; R A Marugg; V Buée-Scherrer; Luc BUEE; André Delacourte; John H Morrison
Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.
Neuroscience 1994;62(1):1-13.
1994: Jean-Philippe David; C Fallet-Bianco; P Vermersch; B Frigard; C Di Menza; André Delacourte
[Normal cerebral aging: study of glial reaction].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(8):749-53.
1994: Patrick Vermersch; Y Robitaille; L Bernier; Annick Wattez; D Gauvreau; André Delacourte
Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.
Acta neuropathologica 1994;87(6):572-7.
1994: Luc BUEE; Patrick R Hof; Constantin Bouras; André Delacourte; Daniel P Perl; John H Morrison; H M Fillit
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Acta neuropathologica 1994;87(5):469-80.
1994: Patrick Vermersch; C Daems-Monpeurt; M Parent; J P Pruvo; André Delacourte; H Petit
[Subcortical dementia of the Neumann type. Contribution of diagnostic imaging].
Revue neurologique 1994;150(5):354-8.
1994: André Delacourte
Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1994;48(7):287-95.
1994: Patrick R Hof; EA Nimchinsky; V Buée-Scherrer; Luc BUEE; J Nasrallah; A F Hottinger; Dushyant P Purohit; A J Loerzel; John C Steele; André Delacourte
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders.
Acta neuropathologica 1994;88(5):397-404.
1993: Luc BUEE; W Ding; J P Anderson; S Narindrasorasak; Robert Kisilevsky; N J Boyle; Nikolaos K Robakis; André Delacourte; Barry D Greenberg; H M Fillit
Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Brain research 1993;627(2):199-204.
1993: Patrick Vermersch; André Delacourte; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
1993: André Delacourte
[Physiopathological bases of Alzheimer disease].
Thérapie 1993;48(3):177-83.
1993: Patrick Vermersch; P E Sautière; M Goudemand; André Delacourte
General cortical involvement in a late-onset case of Alzheimer disease. A biochemical approach by quantitation of abnormal tau proteins.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1993;18(3):213-24.
1993: B Carette; P Poulain; André Delacourte
Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons.
Neuroscience letters 1993;151(1):111-4.
1993: Luc BUEE; W Ding; André Delacourte; H Fillit
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Brain research 1993;601(1-2):154-63.
1993: Philippe Sindou; P E Sautiere; Philippe Couratier; André Delacourte; Jacques Hugon
[Antigenic changes of Tau protein induced by glutamate on primary cultures of neurons: immunocytochemistry study].
Comptes rendus des séances de la Société de biologie et de ses filiales 1993;187(1):87-95.
1993: P E Sautière; Marie-Laure Caillet-Boudin; A Wattez; V Buée-Scherrer; André Delacourte
[Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):533-5.
1992: James C Vickers; André Delacourte; John H Morrison
Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease.
Brain research 1992;594(2):273-8.
1992: Luc BUEE; Patrick R Hof; David D Roberts; André Delacourte; John H Morrison; H M Fillit
Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease.
The American journal of pathology 1992;141(4):783-8.
1992: Patrick Vermersch; B Frigard; Jean-Philippe David; C Fallet-Bianco; André Delacourte
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects.
Neuroscience letters 1992;144(1-2):143-6.
1992: Patrick R Hof; L M Bierer; Daniel P Perl; André Delacourte; Luc BUEE; Constantin Bouras; John H Morrison
Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.
Archives of neurology 1992;49(9):946-53.
1992: P E Sautière; Philippe Sindou; Philippe Couratier; Jacques Hugon; A Wattez; André Delacourte
Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach.
Neuroscience letters 1992;140(2):206-10.
1992: Patrick R Hof; A Charpiot; André Delacourte; Luc BUEE; Dushyant P Purohit; Daniel P Perl; Constantin Bouras
Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism.
Neuroscience letters 1992;139(1):10-4.
1992: Fiona Crawford; Marie-Christine Chartier-Harlin; Michael Mullan; John Hardy; André Delacourte; G Arnott
Alzheimer's--a correction.
Nature 1992;356(6368):390.
1992: C Lucas; M Parent; E Delandsheer; André Delacourte; Y Fournier; A Défossez; Didier LEYS
[Multiple cerebral hemorrhage and amyloid angiopathy of the white matter in a case of Alzheimer's disease].
Revue neurologique 1992;148(3):218-20.
1992: Patrick R Hof; André Delacourte; Constantin Bouras
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.
Acta neuropathologica 1992;84(1):45-51.
1992: Philippe Vallet; R Guntern; Patrick R Hof; J Golaz; André Delacourte; Nikolaos K Robakis; Constantin Bouras
A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.
Acta neuropathologica 1992;83(2):170-8.
1992: Patrick Vermersch; B Frigard; André Delacourte
Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins.
Acta neuropathologica 1992;85(1):48-54.
1992: Patrick R Hof; Constantin Bouras; Luc BUEE; André Delacourte; Daniel P Perl; John H Morrison
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases.
Acta neuropathologica 1992;85(1):23-30.
1991: N Behrouz; A Defossez; André Delacourte; M Mazzuca
The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease.
Journal of gerontology 1991;46(6):B209-12.
1991: Irène Ceballos-Picot; Annie Nicole; Pascale Briand; G Grimber; André Delacourte; A Defossez; France Javoy-Agid; M Lafon; J L Blouin; Pierre-Marie Sinet
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Brain research 1991;552(2):198-214.
1991: A Defossez; André Delacourte; M Mazzuca
[Brain lesions in Alzheimer's disease: contribution of ultrastructural observations].
Bulletin de l'Association des anatomistes 1991;75(229):89-92.
1991: Luc BUEE; N J Boyle; L B Zhang; André Delacourte; H M Fillit
Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycans and proteoglycans.
Analytical biochemistry 1991;195(2):238-42.
1991: A Furby; D Leys; André Delacourte; Luc BUEE; G Soetaert; H Petit
Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):469.
1991: I Ceballos; France Javoy-Agid; André Delacourte; A Defossez; M Lafon; Etienne C Hirsch; Annie Nicole; Pierre-Marie Sinet; Yves Agid
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
1991: Didier LEYS; Jean-Pierre Pruvo; M Parent; P Vermersch; G Soetaert; M Steinling; André Delacourte; A Défossez; A Rapoport; J Clarisse
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?
Journal of neurology, neurosurgery, and psychiatry 1991;54(1):46-50.
1991: S Flament; André Delacourte; M Verny; JEAN-JACQUES HAUW; France Javoy-Agid
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
Acta neuropathologica 1991;81(6):591-6.
1991: I Ceballos; Annie Nicole; Pascale Briand; G Grimber; André Delacourte; S Flament; J L Blouin; M Thevenin; Pierre Kamoun; Pierre-Marie Sinet
Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
Free radical research communications 1991;12-13 Pt 2():581-9.
1990: S Flament; André Delacourte
Tau marker?
Nature 1990;346(6279):22.
1990: S Flament; André Delacourte; D M A Mann
Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome.
Brain research 1990;516(1):15-9.
1990: N Behrouz; A Defossez; André Delacourte; M Mazzuca
Cortical beta-amyloid.
Nature 1990;344(6266):497.
1990: André Delacourte; S Flament; A Defossez
[Towards the development of an in vivo study model of Alzheimer-type neurofibrillary degeneration].
Presse médicale (Paris, France : 1983) 1990;19(4):170-3.
1990: André Delacourte
General and dramatic glial reaction in Alzheimer brains.
Neurology 1990;40(1):33-7.
1990: I Ceballos; France Javoy-Agid; André Delacourte; A Defossez; Annie Nicole; Pierre-Marie Sinet
Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?
Advances in experimental medicine and biology 1990;264():493-8.
1990: André Delacourte
[Experimental approach to neuronal degeneration].
Comptes rendus des séances de la Société de biologie et de ses filiales 1990;184(1):5-17.
1990: S Flament; André Delacourte; P Delaère; Charles Duyckaerts; JEAN-JACQUES HAUW
Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.
Acta neuropathologica 1990;80(2):212-5.
1990: André Delacourte; S Flament; E M Dibe; P Hublau; B Sablonnière; B Hémon; V Shérrer; A Défossez
Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
Acta neuropathologica 1990;80(2):111-7.
1990: N Behrouz; A Defossez; André Delacourte; M Mazzuca
[Alzheimer's disease: the beta amyloid protein A4 is also present in the cortical white matter].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;310(11):539-44.
1989: N Behrouz; A Defossez; André Delacourte; P Hublau; M Mazzuca
An antiserum to the N-terminal subsequence of the Alzheimer amyloid beta protein does not react with neurofibrillary tangles.
Journal of gerontology 1989;44(6):B156-9.
1989: Luc BUEE; A Laine; André Delacourte; S Flament; K K Han
Qualitative and quantitative comparison of brain proteins in Alzheimer's disease.
Biological chemistry Hoppe-Seyler 1989;370(11):1229-34.
1989: N Behrouz; A Defossez; André Delacourte; P Hublau; M Mazzuca
Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
Laboratory investigation; a journal of technical methods and pathology 1989;61(5):576-83.
1989: D M A Mann; D Prinja; Christine Ann Davies; Yasuo Ihara; André Delacourte; A Défossez; R J Mayer; M Landon
Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages.
Journal of the neurological sciences 1989;92(2-3):247-60.
1989: S Flament; André Delacourte; B Hémon; A Défossez
Characterization of two pathological tau protein, variants in Alzheimer brain cortices.
Journal of the neurological sciences 1989;92(2-3):133-41.
1989: Mario Rosemblatt; A Fellous; J C Mazie; André Delacourte; A Defossez
Alzheimer's disease: microtubule-associated proteins 2 (MAP 2) are not components of paired helical filaments.
FEBS letters 1989;252(1-2):91-4.
1989: M B Lenders; M C Peers; G Tramu; André Delacourte; A Defossez; H Petit; M Mazzuca
Dystrophic neuropeptidergic neurites in senile plaques of Alzheimer's disease precede formation of paired helical filaments.
Acta neurologica Belgica 1989;89(3-4):279-85.
1989: André Delacourte; S Flament; N Behrouz; A Defossez
[Alzheimer's disease: tau microtubular protein and beta protein A4 constitute 2 different types of amyloid substance].
Acta neurologica Belgica 1989;89(3-4):274-5.
1989: S Flament; André Delacourte
Abnormal tau species are produced during Alzheimer's disease neurodegenerating process.
FEBS letters 1989;247(2):213-6.
1989: M B Lenders; M C Peers; G Tramu; André Delacourte; A Defossez; H Petit; M Mazzuca
Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments.
Brain research 1989;481(2):344-9.
1989: N Behrouz; A Defossez; André Delacourte; P Hublau; M Mazzuca
[Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(16):437-44.
1989: André Delacourte; Luc BUEE
[Alzheimer's disease: the glial reaction is general and severe in all areas of the central nervous system].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(13):359-65.
1989: S Flament; André Delacourte; B Hemon; A Defossez
[Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(3):77-82.
1988: André Delacourte; A Defossez; I Ceballos; Annie Nicole; Pierre-Marie Sinet
Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease.
Neuroscience letters 1988;92(3):247-53.
1988: P Amouyel; A Gégonne; André Delacourte; A Défossez; D Stéhelin
Expression of ETS proto-oncogenes in astrocytes in human cortex.
Brain research 1988;447(1):149-53.
1988: M C Peers; M B Lenders; A Défossez; André Delacourte; M Mazzuca
Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels.
Virchows Archiv. A, Pathological anatomy and histopathology 1988;414(1):15-20.
1988: M Parent; André Delacourte; A Défossez; B Hémon; K K Han; H Petit
[Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1988;306(13):391-7.
1988: A Defossez; Jean-Claude Beauvillain; André Delacourte; M Mazzuca
Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling.
Virchows Archiv. A, Pathological anatomy and histopathology 1988;413(2):141-5.
1987: André Delacourte; G Vuillon-Cacciuttolo; O Bosler
GABA nerve endings in the rat red nucleus combined detection with serotonin terminals using dual immunocytochemistry.
Neuroscience 1987;23(3):1095-102.
1987: A Défossez; André Delacourte
Transformation of degenerating neurofibrils into amyloid substance in Alzheimer's disease: histochemical and immunohistochemical studies.
Journal of the neurological sciences 1987;81(1):1-10.
1987: A Salhi; André Delacourte; J C Guyot; B Boniface
[Simple tests for the evaluation of the moist granule. Application to the optimization of the amount of moistening liquid].
Il Farmaco; edizione pratica 1987;42(3):59-79.
1987: K K Han; André Delacourte; B Hemon
Chemical modification of thiol group(s) in protein: application to the study of anti-microtubular drugs binding.
Comparative biochemistry and physiology. B, Comparative biochemistry 1987;88(4):1057-65.
1987: A Defossez; Khalid H El Hachimi; Jean-Claude Beauvillain; J Perre; André Delacourte; J F Foncin
[Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1987;304(9):217-22.
1987: André Delacourte; A Defossez; P Persuy; M C Peers
Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease.
Virchows Archiv. A, Pathological anatomy and histopathology 1987;411(3):199-204.
1986: André Delacourte; A Defossez
Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.
Journal of the neurological sciences 1986;76(2-3):173-86.
1986: A Defossez; P Persuy; G Tramu; André Delacourte
[Immunohistochemical study of the basic lesions of Alzheimer's disease].
L'Encéphale 1986;12(4):161-8.
1986: S Mahboub; C Richard; André Delacourte; K K Han
Applications of chemical cleavage procedures to the peptide mapping of neurofilament triplet protein bands in sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Analytical biochemistry 1986;154(1):171-82.
1986: I Lesieur; Daniel Lesieur; C Lespagnol; M Cazin; Claude Brunet; Michel Luyckx; M L Mallevais; André Delacourte; Luc Dubreuil; J Devos
Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones.
Arzneimittel-Forschung 1986;36(1):20-4.
1986: S Mahboub; B Hemon; A Defossez; André Delacourte; K K Han
Biochemical and immunological studies of bovine and porcine neurofilament triplet proteins by peptide mapping after cyanogen bromide cleavage.
Comparative biochemistry and physiology. B, Comparative biochemistry 1986;85(2):299-306.
1986: André Delacourte; A Défossez
[Biochemical characterization of an immune serum which specifically marks neurons in neurofibrillary degeneration in Alzheimer's disease].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;303(11):439-44.
1986: K K Han; C Richard; G Y Zhang; André Delacourte
Sequence homology analysis of proteins by chemical cleavages: using a mono and two dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The International journal of biochemistry 1986;18(12):1073-82.
1985: Claude Brunet; Michel Luyckx; M Cazin; I Lesieur; Daniel Lesieur; C Lespagnol; André Delacourte; M L Mallevais
Pharmacological study of nine antimicrotubular drugs with acrylophenone structure on Triton WR 1339-induced hyperlipidemia in rats.
Methods and findings in experimental and clinical pharmacology 1985;7(11):579-83.
1985: J M Bard; Michel Luyckx; Claude Brunet; M Cazin; J C Fruchart; V Clavey; I Lesieur; Daniel Lesieur; André Delacourte
Normolipemic activities of acrylophenone derivatives with antimicrotubular properties.
Methods and findings in experimental and clinical pharmacology 1985;7(4):183-7.
1985: C Richard; S Mahboub; André Delacourte; B Hemon; K K Han
Comparative studies of the neurofilament triplet protein peptide mapping by chemical cleavage.
Comparative biochemistry and physiology. B, Comparative biochemistry 1985;80(4):707-12.
1985: P Persuy; A Defossez; André Delacourte; G Tramu; B Bouchez; G Arnott
Anti-PHF antibodies: an immunohistochemical marker of the lesions of the Alzheimer's disease. Characterization and comparison with Bodian's silver impregnation.
Virchows Archiv. A, Pathological anatomy and histopathology 1985;407(1):13-23.
1984: M L Mallevais; André Delacourte; Michel Luyckx; M Cazin; Claude Brunet; Daniel Lesieur
Antimicrotubular effects of ethacrynic acid.
Methods and findings in experimental and clinical pharmacology 1984;6(11):675-7.
1984: M L Mallevais; André Delacourte; I Lesieur; Daniel Lesieur; M Cazin; Claude Brunet; Michel Luyckx
2-(4-methyl-1-piperazinylmethyl) acrylophenone dihydrochloride: a new antimicrotubular drug.
Biochimie 1984;66(6):477-82.
1984: Claude Brunet; Michel Luyckx; M Cazin; A Chaoui; I Lesieur; Daniel Lesieur; André Delacourte
Preliminary note: effect of microtubule inhibitors with acrylophenone structure on Triton WR 1339 induced hyperlipidemia in rats.
Methods and findings in experimental and clinical pharmacology 1984;6(5):227-30.
1984: C Francois; André Delacourte; K K Han; M Mazzuca
Accessibility and cross-linking of native neurofilaments to chemical reagents.
The International journal of biochemistry 1984;16(5):461-7.
1982: André Delacourte; M Dousti; M H Loucheux-Lefebvre
Characterization of mammalian neurofilament subunits by circular dichroism.
Biochimica et biophysica acta 1982;709(1):99-104.
1982: A Prochiantz; André Delacourte; M C Daguet; D Paulin
Intermediate filament proteins in mouse brain cells cultured in the presence or absence of fetal calf serum.
Experimental cell research 1982;139(2):404-10.
1981: G Filliatreau; L Di Giamberardino; André Delacourte; F Boutteau; G Biserte
[Polypeptide composition of neurofilaments of birds].
Biochimie 1981;63(4):369-71.
1981: Y Plancke; André Delacourte; G Biserte
Preparation of neurofilaments from three different sources.
Biochimie 1981;63(4):365-7.
1980: André Delacourte; G Filliatreau; F Boutteau; G Biserte; J Schrevel
Study of the 10-nm-filament fraction isolated during the standard microtubule preparation.
The Biochemical journal 1980;191(2):543-6.
1979: R Thorpe; André Delacourte; M Ayers; C Bullock; B H Anderton
The polypeptides of isolated brain 10nm filaments and their association with polymerized tubulin.
The Biochemical journal 1979;181(2):275-84.
1979: R Thorpe; André Delacourte; Brian H Anderton
The isolation of brain 10 nm filament polypeptides from urea-extracts of brain white matter.
FEBS letters 1979;103(1):148-51.
1978: P Colombo; U Conte; C Caramella; A La Manna; J C Guyot; André Delacourte; B Devise; M Traisnel; M Boniface
The relevance of viscous behaviour to stress/displacement relationship in pharmaceutical powders compression.
Il Farmaco; edizione pratica 1978;33(12):531-42.
1978: D Bout; H Dupas; M Capron; A E Gazawi; Y Carlier; André Delacourte; A Capron
Purification, immunochemical and biological characterization of malate dehydrogenase of Schistosoma mansoni.
Immunochemistry 1978;15(9):633-8.
1977: André Delacourte; M T Plancot; K K Han; H Hildebrand; G Biserte
Investigation of tubulin fibers formed during microtubule polymerization cycles.
FEBS letters 1977;77(1):41-6.
1977: André Delacourte; M T Plancot; F Boutteau; K K Han; H F Hildebrand; G Biserte
[Preparation of highly purified microbules and evidence for a novel molecular arrangement at low temperatures].
Biochimie 1977;59(5-6):479-86.
1977: M T Plancot; André Delacourte; K K Han; M Dautrevaux; G Biserte
Isolation and characterization of highly purified alpha-1-antitrypsin.
International journal of peptide and protein research 1977;10(2):113-9.
1973: André Delacourte; K K Han; M Dautrevaux
[Alkylation of histidine residues of horse myoglobin. Study of 1-CM His-113 myoglobin].
Biochimie 1973;55(8):869-76.